• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Shanghai Junshi Biosciences

heart
Posted inCardiology, Clinical Trials, In the Pipeline, Metabolism

Enlicitide: Very Strong Pill Against ‘Bad’ Cholesterol

by Julia Mardi February 27, 2024April 19, 2024

The oral drug by Merck & Co. smashes all competitors for the treatment and prevention of atherosclerosis.

coronavirus Omicron
Posted inCOVID-19, Infections, Research

Omicron Treatment: Most Effective Drugs

by Tanya von Reuss and Timur Burkhanayev August 31, 2022September 8, 2022

Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.

Posted inCOVID-19, Infections, New Drugs, Regulatory

Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus

by Mark Gubar June 8, 2022September 8, 2022

One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.

coronavirus
Posted inCOVID-19, Infections, Research

Omicron Variant: Latest Scientific News, Findings, Evidence, and Developments

by Nik Resovski and Timur Burkhanayev December 17, 2021April 11, 2024

Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.

BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×